Rhabdomyosarcoma (RMS) is a malignant neoplasm derived from premature mesenchymal cells showing striated muscle differentiation. It is the most common soft-tissue malignancy in the pediatric population, occurring in the head and neck. 1,2 In the adult population, RMS is extremely rare, carrying a poor prognosis, and the literature is limited on the management and outcome of this tumor. 3 We evaluated a 25-year-old man with a history of chronic headaches, nasal congestion, and right-sided vision impairment worsening over the preceding month. Physical examination showed no other systemic manifestations or cranial nerve palsies. Computed tomography (CT) showed a homogeneous tumor involving the right frontal lobes extending from the sinonasal area. Magnetic resonance imaging (MRI) confirmed the presence of a large sinonasal tumor extending into the medial orbits with a large intracranial component ( figure 1) .
B
Rhabdomyosarcoma (RMS) is a malignant neoplasm derived from premature mesenchymal cells showing striated muscle differentiation. It is the most common soft-tissue malignancy in the pediatric population, occurring in the head and neck. 1, 2 In the adult population, RMS is extremely rare, carrying a poor prognosis, and the literature is limited on the management and outcome of this tumor. 3 We evaluated a 25-year-old man with a history of chronic headaches, nasal congestion, and right-sided vision impairment worsening over the preceding month. Physical examination showed no other systemic manifestations or cranial nerve palsies. Computed tomography (CT) showed a homogeneous tumor involving the right frontal lobes extending from the sinonasal area. Magnetic resonance imaging (MRI) confirmed the presence of a large sinonasal tumor extending into the medial orbits with a large intracranial component ( figure 1 ).
The ultimate diagnosis of sinonasal RMS, specifically the embryonal subtype, was made through a transnasal endoscopic biopsy (figure 2). Further sys- temic survey-including body imaging, bone scan, and lumbar puncture-revealed no evidence of neoplastic dissemination. Initial reduction of the tumor was approached with induction chemotherapy and extensive surgical removal of the mass via a craniofacial approach. A postoperative MRI with contrast enhancement revealed extensive sinonasal resection with no gross evidence of residual tumor (figure 3). The patient was subsequently treated with chemoradiation. After the surgery, the patient had right medial rectus weakness and facial pain that partially responded to medical management. No evidence of recurrence was seen at the 2-year follow-up, either clinically or by imaging.
IMAGING CLINIC
RMSs are extremely rare in the adult population. In the head and neck they often present with nonspecific symptoms such as headache, nasal congestion, proptosis, epistaxis, and cranial nerve palsies, reflecting extension to the base of the skull. The main histologic types are embryonal (71%) and alveolar (13%). 3 They usually carry a poor prognosis due to skull base and intracranial extension. 4 They also have the potential for cerebrospinal fluid dissemination, as well as distant metastasis to the lungs, cervical lymph nodes, and bones. [4] [5] [6] Imaging of RMS with CT and MRI is essential for diagnosis and for the evaluation of the high rate of metastatic disease. 4 Despite great advances in therapy, only a small increase in the 5-year survival rate for adult RMS has been shown. 7 A good response was attained in our patient, perhaps because the tumor was of the embryonal type, and because of the multimodality therapy, resulting in an apparent complete remission of the tumor. Our patient remains free of recurrence after 2 years. 
